Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Providing donor stool to treat patients with bowel conditions and foster research into faecal transplant as a treatment.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
With support from The Hospital Research Foundation (THRF), Dr Katharina Richter has developed a new gel treatment currently in clinical trials to fight superbugs, antibiotic-resistant bacteria like golden staph.
With the clinical trial now underway at The Queen Elizabeth Hospital (TQEH), the gel has been tested and developed by Dr Richter to target superbug’s favourite food – iron.
Did you know that superbugs cause 700,000 deaths globally each year? The World Health Organisation predicts by 2050, 10million people will die each year from antibiotic-resistant bacteria. Dr Richter’s new treatment could be the key to fighting this scary statistic!
“Iron is like chocolate for bacteria. It gives them energy to grow, cause disease, and withstand attacks from our immune systems and antibiotics,” Dr Richter said.
“Using two different compounds, we first starve the bacteria of iron and then feed them the bacterial equivalent of poisonous chocolate, which the hungry bacteria find irresistible.”
This new approach is being trialled to treat patients with chronic recurring sinus infections at TQEH with Ear, Nose and Throat Surgeon Professor Peter-John Wormald.
Dr Richter’s life-changing treatment was featured in 9 News Adelaide, watch the story below!
If you have a chronic recurring sinus infection and interested in being involved in the trial, contact your General Practitioner to receive a referral to visit an Ear, Nose and Throat Specialist at TQEH.
support research at the queen elizabeth hospital